References
- Burnier L, Fontana P, Kwak BR, Angelillo-Scherrer A. Cell-derived microparticles in haemostasis and vascular medicine. Thromb Haemost. 2009; 101: 439–51. 10.1160/TH08-08-0521.
- Castellana D, Toti F, Freyssinet J-M. Membrane microvesicles: macromessengers in cancer disease and progression. Thromb Res. 2010; 125: S84–8.
- Cocucci E, Meldolesi J. Ectosomes. CURBIO. 2011; 21: R940–1.
- Théry C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 2009; 9: 581–93.
- Al-Nedawi K, Meehan B, Rak J. Microvesicles: messengers and mediators of tumor progression. Cell Cycle. 2009; 8: 2014–8.
- Lee TH, D‘Asti E, Magnus N, Al-Nedawi K, Meehan B, Rak J. Microvesicles as mediators of intercellular communication in cancer—the emerging science of cellular ‘debris’. Semin Immunopathol. 2011; 33: 455–67.
- Cocucci E, Racchetti G, Meldolesi J. Shedding microvesicles: artefacts no more. Trends Cell Biol. 2009; 19: 43–51.
- Muller I. Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets. FASEB J. 2003; 17: 476–8. 10.1096/fj.02-0574fje.
- Del Conde I. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood. 2005; 106: 1604–11.
- Fleissner F, Goerzig Y, Haverich A, Thum T. Microvesicles as novel biomarkers and therapeutic targets in transplantation medicine. Am J Transplant. 2011; 12: 289–97.
- Van Doormaal FF, Kleinjan A, Di Nisio M, Büller HR, Nieuwland R. Cell-derived microvesicles and cancer. Neth J Med. 2009; 67: 266–73.
- Mullier F, Bailly N, Cornet Y, Dubuc E, Robert S, Osselaer J, etal. Contribution of platelet microparticles generation assay to the diagnosis of type II heparin-induced thrombocytopenia. Thromb Haemost. 2010; 103: 1277–81.
- Mullier F, Bailly N, Chatelain C, Dogné JM, Chatelain B. More on: calibration for the measurement of microparticles: needs, interests, and limitations of calibrated polystyrene beads for flow cytometry-based quantification of biological microparticles. J Thromb Haemost. 2011; 9: 1679–81.
- Fatemeh M-H. Alternative methods for characterization of extracellular vesicles. Neth J Med. 2013; 3: 266–73. 10.3389/fphys.2012.00354/abstract.
- Van der Pol E, Hoekstra AG, Sturk1 A, Otto C, van Leeuwen TG, Nieuwland R. Optical and non-optical methods for detection and characterization of microparticles and exosomes. J Thromb Haemost. 2010; 8: 2596–607.
- Yuana Y, Oosterkamp TH, Bahatyrova S, Ashcroft B, Garcia Rodriguez P, Bertina RM, etal. Atomic force microscopy: a novel approach to the detection of nanosized blood microparticles. J Thromb Haemost. 2010; 8: 315–23.
- Hugel B. Membrane microparticles: two sides of the coin. Physiology. 2005; 20: 22–7.
- Sharma S, Rasool HI, Palanisamy V, Mathisen C, Schmidt M, Wong DT, etal. Structural-mechanical characterization of nanoparticle exosomes in human saliva, using correlative AFM, FESEM, and force spectroscopy. ACS Nano. 2010; 4: 1921–6.
- Muller DJ, Dufrêne YF. Atomic force microscopy: a nanoscopic window on the cell surface. Trends Cell Biol. 2011; 21: 461–9.
- Davila M, Amirkhosravi A, Coll E, Desai H, Robles L, Colon J, etal. Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation. J Thromb Haemost. 2008; 6: 1517–24.
- Gheldof D, Hardij J, Cecchet F, Chatelain B, Dogné J, Mullier F. Thrombin generation assay and transmission electron microscopy: a useful combination to study tissue factor-bearing microvesicles. J Extracell Vesicles. 2013; 2 19728, doi: http://dx.doi.org/10.3402/jev.v2i0.19728.
- Mullier F, Bailly N, Chatelain C, Chatelain B, Dogné JM. Pre-analytical issues in the measurement of circulating microparticles: current recommendations and pending questions. J Thromb Haemost. 2013; 11: 693–6.
- Klein DCG, Stroh CM, Jensenius H, van Es M, Kamruzzahan AS, Stamouli A, etal. Covalent immobilization of single proteins on mica for molecular recognition force microscopy. ChemPhysChem. 2003; 4: 1367–71.